Qu Shuang, Jiao Zichen, Lu Geng, Xu Jiahan, Yao Bing, Wang Ting, Wang Jun, Yao Yongzhong, Yan Xin, Wang Tao, Liang Hongwei, Zen Ke
Department of Thoracic Surgery, State Key Laboratory of Pharmaceutical Biotechnology, Drum Tower Hospital, Nanjing University Medical School, Nanjing, Jiangsu 210093, China.
School of Life Science and Technology, China Pharmaceutical University, 639 Longmian Avenue, Nanjing, Jiangsu 211198, China.
Mol Ther Oncolytics. 2022 May 3;25:276-287. doi: 10.1016/j.omto.2022.04.011. eCollection 2022 Jun 16.
Tumor cells can evade attack by phagocytes by upregulating the self-marker CD47. The mechanisms underlying tumor CD47 upregulation, however, remain unclear. Here, we report that human lung adenocarcinoma CD47 is upregulated by interferon-γ (IFN-γ), the level in the tumor microenvironment of which is markedly increased after tumor metastasis and chemotherapy. The IFN-γ receptor is expressed in various human lung adenocarcinoma tissues regardless of the CD47 protein expression, and lung adenocarcinoma CD47 expression is significantly enhanced following tumor metastasis or chemotherapy treatment. In line with this, CD47 expression in various lung cancer cells is markedly increased by IFN-γ treatment. Mechanistically, IFN-γ promotes CD47 expression by activating interferon regulatory factor-1 (IRF-1), which binds to an IRF-1-binding domain within the CD47 promoter region and increases CD47 transcription. Functionally, IFN-γ-enhanced CD47 expression facilitates human lung cancer cell invasion both and , whereas IFN-γ-induced CD47 upregulation and cancer metastasis are blocked by mutating the IRF-1-binding site within the CD47 promoter. Our results reveal IFN-γ-enhanced CD47 expression as a novel mechanism promoting human lung adenocarcinoma progression.
肿瘤细胞可通过上调自身标志物CD47来逃避吞噬细胞的攻击。然而,肿瘤细胞CD47上调的机制仍不清楚。在此,我们报告人类肺腺癌中的CD47受干扰素-γ(IFN-γ)上调,在肿瘤转移和化疗后,其在肿瘤微环境中的水平显著增加。无论CD47蛋白表达如何,IFN-γ受体在各种人类肺腺癌组织中均有表达,且在肿瘤转移或化疗治疗后,肺腺癌CD47表达显著增强。与此一致,IFN-γ处理可使各种肺癌细胞中的CD47表达明显增加。机制上,IFN-γ通过激活干扰素调节因子-1(IRF-1)来促进CD47表达,IRF-1与CD47启动子区域内的IRF-1结合域结合并增加CD47转录。功能上,IFN-γ增强的CD47表达促进人肺癌细胞侵袭,而通过突变CD47启动子内的IRF-1结合位点可阻断IFN-γ诱导的CD47上调和癌症转移。我们的结果揭示了IFN-γ增强的CD47表达是促进人类肺腺癌进展的一种新机制。